Hemanext Archives

Science Innovation Forum

Science & Innovation Forum – The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. When: Thursday, May 5, 2022 4:00 – 5:00 PM (ET)...

Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation

Hemanext, Press Release

LEXINGTON, Mass., February 02, 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing, storage, and transfusion technology, is proud to announce a new partnership with The Aplastic Anemia & MDS International...

Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB

Hemanext, HemanextInvS, Press Release

LEXINGTON, Mass., January 24, 2022, PR NEWSWIRE – Hemanext Inc. today announced that Hemanext ONE®, its innovative blood processing and storage system, has been recognized by the Association for the Advancement of Blood & Biotherapies (“AABB”), a...

Hemanext Submits Hemanext ONE System to FDA For U.S. Marketing Authorization

Hemanext, HemanextInvF, News, Press Release

Innovative Blood Processing and Storage System Received CE Mark Certification for Sale in European Markets Last Year LEXINGTON, Mass., January 5, 2022, PR NEWSWIRE – Hemanext Inc., a leading innovator in blood processing and storage technology, announced that it...

Hemanext AABB 2021

Events, Hemanext, News

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs). Learn More...

Hemanext Announces that Hypoxic Blood Storage Study has been Recognized as Best Original Research Paper by AABB

Hemanext, Press Release

Research supports Hemanext’s aim to improve clinical outcomes of transfusion recipients with its innovative red blood cell processing and storage system. LEXINGTON, Mass., September 21, 2021, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the...

« Older Entries

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE